Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Microglial Cells: The Main HIV-1 Reservoir in the Brain.

Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, Schwartz C.

Front Cell Infect Microbiol. 2019 Oct 24;9:362. doi: 10.3389/fcimb.2019.00362. eCollection 2019. Review.

2.

Static and dynamic network properties of the repetitive transcranial magnetic stimulation target predict changes in emotion regulation in obsessive-compulsive disorder.

Douw L, Quaak M, Fitzsimmons SMDD, de Wit SJ, van der Werf YD, van den Heuvel OA, Vriend C.

Brain Stimul. 2019 Oct 24. pii: S1935-861X(19)30426-7. doi: 10.1016/j.brs.2019.10.017. [Epub ahead of print]

3.

The EuroSIDA study: 25 years of scientific achievements.

Laut K, Kirk O, Rockstroh J, Phillips A, Ledergerber B, Gatell J, Gazzard B, Horban A, Karpov I, Losso M, d'Arminio Monforte A, Pedersen C, Ristola M, Reiss P, Scherrer AU, de Wit S, Aho I, Rasmussen LD, Svedhem V, Wandeler G, Pradier C, Chkhartishvili N, Matulionyte R, Oprea C, Kowalska JD, Begovac J, Miró JM, Guaraldi G, Paredes R, Raben D, Podlekareva D, Peters L, Lundgren JD, Mocroft A.

HIV Med. 2019 Oct 24. doi: 10.1111/hiv.12810. [Epub ahead of print]

PMID:
31647187
4.

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.

Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D'Arminio Monforte A, Mocroft A, Pradier C, Kirk O, Kovari H, Bonnet F, El-Sadr W, Lundgren JD, Sabin C; D:A:D Study Group.

EClinicalMedicine. 2019 Aug 11;13:91-100. doi: 10.1016/j.eclinm.2019.07.008. eCollection 2019 Aug.

5.

Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.

Ryom L, Dilling Lundgren J, Reiss P, Kirk O, Law M, Ross M, Morlat P, Andreas Fux C, Fontas E, De Wit S, D'Arminio Monforte A, El-Sadr W, Phillips A, Ingrid Hatleberg C, Sabin C, Mocroft A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

J Infect Dis. 2019 Oct 8;220(10):1629-1634. doi: 10.1093/infdis/jiz369.

PMID:
31504669
6.

High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study.

Beun AJ, Grammens T, Hainaut M, Barlow P, Van den Wijngaert S, Delforge M, De Wit S, Dauby N.

Vaccine. 2019 Sep 20;37(40):5930-5933. doi: 10.1016/j.vaccine.2019.08.034. Epub 2019 Aug 23.

PMID:
31451323
7.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.

Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d'Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD; HIDES Study Group.

PLoS One. 2019 Aug 13;14(8):e0220108. doi: 10.1371/journal.pone.0220108. eCollection 2019.

8.

Serious clinical events in HIV-positive persons with chronic kidney disease.

Ryom L, Lundgren JD, Law M, Kirk O, El-Sadr W, Bonnet F, Weber R, Fontas E, Monforte AD, Phillips A, Reiss P, de Wit S, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.

AIDS. 2019 Nov 15;33(14):2173-2188. doi: 10.1097/QAD.0000000000002331.

PMID:
31385862
9.

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors.

Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen LWMM, Groen HJM.

J Immunother Cancer. 2019 Jul 10;7(1):173. doi: 10.1186/s40425-019-0649-2.

10.

Identification and characterization of Dutch Avibacterium paragallinarum isolates and the implications for diagnostics.

Feberwee A, Dijkman R, Buter R, Soriano-Vargas E, Morales-Erasto V, Heuvelink A, Fabri T, Bouwstra R, de Wit S.

Avian Pathol. 2019 Dec;48(6):549-556. doi: 10.1080/03079457.2019.1641178. Epub 2019 Jul 24.

PMID:
31280592
11.

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.

Eron JJ, Orkin C, Cunningham D, Pulido F, Post FA, De Wit S, Lathouwers E, Hufkens V, Jezorwski J, Petrovic R, Brown K, Van Landuyt E, Opsomer M; EMERALD study group.

Antiviral Res. 2019 Oct;170:104543. doi: 10.1016/j.antiviral.2019.104543. Epub 2019 Jul 4.

12.

The Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation on Emotion Processing, Reappraisal, and Craving in Alcohol Use Disorder Patients and Healthy Controls: A Functional Magnetic Resonance Imaging Study.

Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE.

Front Psychiatry. 2019 May 7;10:272. doi: 10.3389/fpsyt.2019.00272. eCollection 2019.

13.

Emotion Processing, Reappraisal, and Craving in Alcohol Dependence: A Functional Magnetic Resonance Imaging Study.

Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE.

Front Psychiatry. 2019 Apr 9;10:227. doi: 10.3389/fpsyt.2019.00227. eCollection 2019.

14.

Dolutegravir-induced extrapyramidal syndrome in a young woman.

Dauby N, Bartholomé E, De Wit S.

AIDS. 2019 Mar 15;33(4):763-764. doi: 10.1097/QAD.0000000000002107. No abstract available.

PMID:
30829747
15.

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments.

Kula A, Delacourt N, Bouchat S, Darcis G, Avettand-Fenoel V, Verdikt R, Corazza F, Necsoi C, Vanhulle C, Bendoumou M, Burny A, De Wit S, Rouzioux C, Rohr O, Van Lint C.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):605-613. doi: 10.1097/QAI.0000000000001958.

PMID:
30768485
16.

Goal-Directed and Habitual Control in Smokers.

Luijten M, Gillan CM, De Wit S, Franken IHA, Robbins TW, Ersche KD.

Nicotine Tob Res. 2019 Feb 15. pii: ntz001. doi: 10.1093/ntr/ntz001. [Epub ahead of print]

PMID:
30768206
17.

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.

Bernardino JI, Mocroft A, Wallet C, de Wit S, Katlama C, Reiss P, Mallon PW, Richert L, Molina JM, Knobel H, Morlat P, Babiker A, Pozniac A, Raffi F, Arribas JR; NEAT001/ANRS143 Trial Study Group.

PLoS One. 2019 Jan 28;14(1):e0209911. doi: 10.1371/journal.pone.0209911. eCollection 2019.

18.

Prevalence, Risk Factors, and Serotype Distribution of Group B Streptococcus Colonization in HIV-Infected Pregnant Women Living in Belgium: A Prospective Cohort Study.

Dauby N, Adler C, Miendje Deyi VY, Sacheli R, Busson L, Chamekh M, Marchant A, Barlow P, De Wit S, Levy J, Melin P, Goetghebuer T.

Open Forum Infect Dis. 2018 Nov 30;5(12):ofy320. doi: 10.1093/ofid/ofy320. eCollection 2018 Dec.

19.

Error Processing and Inhibitory Control in Obsessive-Compulsive Disorder: A Meta-analysis Using Statistical Parametric Maps.

Norman LJ, Taylor SF, Liu Y, Radua J, Chye Y, De Wit SJ, Huyser C, Karahanoglu FI, Luks T, Manoach D, Mathews C, Rubia K, Suo C, van den Heuvel OA, Yücel M, Fitzgerald K.

Biol Psychiatry. 2019 May 1;85(9):713-725. doi: 10.1016/j.biopsych.2018.11.010. Epub 2018 Nov 29.

PMID:
30595231
20.

Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

Lemoine M, Assoumou L, De Wit S, Girard PM, Valantin MA, Katlama C, Necsoi C, Campa P, Huefner AD, Schulze Zur Wiesch J, Rougier H, Bastard JP, Stocker H, Mauss S, Serfaty L, Ratziu V, Menu Y, Schlue J, Behrens G, Bedossa P, Capeau J, Ingiliz P, Costagliola D; ANRS-ECHAM Group.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):e86-e94. doi: 10.1097/QAI.0000000000001936.

PMID:
30570529
21.

Single tube liquid biopsy for advanced non-small cell lung cancer.

de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, Terstappen LWMM, Groen HJM.

Int J Cancer. 2019 Jun 15;144(12):3127-3137. doi: 10.1002/ijc.32056. Epub 2019 Jan 28.

PMID:
30536653
22.

HIV virological failure in a patient with human T-lymphotropic virus type 1-associated leukemia.

Nasreddine R, de Wind R, De Wit S, Martin C.

AIDS. 2019 Jan 27;33(1):159-160. doi: 10.1097/QAD.0000000000002013. No abstract available.

PMID:
30507628
23.

Social media and depression symptoms: A network perspective.

Aalbers G, McNally RJ, Heeren A, de Wit S, Fried EI.

J Exp Psychol Gen. 2019 Aug;148(8):1454-1462. doi: 10.1037/xge0000528. Epub 2018 Dec 3.

PMID:
30507215
24.

Epidemiology and clinical management of HIV-HBV coinfected patients in a large AIDS Reference Center in Belgium.

Farid Y, Martin C, Delforge M, De Wit S.

Acta Clin Belg. 2019 Dec;74(6):424-429. doi: 10.1080/17843286.2018.1554292. Epub 2018 Dec 4.

PMID:
30513065
25.

EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.

de Wit S, Manicone M, Rossi E, Lampignano R, Yang L, Zill B, Rengel-Puertas A, Ouhlen M, Crespo M, Berghuis AMS, Andree KC, Vidotto R, Trapp EK, Tzschaschel M, Colomba E, Fowler G, Flohr P, Rescigno P, Fontes MS, Zamarchi R, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Farace F, De Bono J, IJzerman MJ, Terstappen LWMM.

Oncotarget. 2018 Nov 2;9(86):35705-35716. doi: 10.18632/oncotarget.26298. eCollection 2018 Nov 2.

26.

Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.

Sarracino A, Gharu L, Kula A, Pasternak AO, Avettand-Fenoel V, Rouzioux C, Bardina M, De Wit S, Benkirane M, Berkhout B, Van Lint C, Marcello A.

MBio. 2018 Nov 13;9(6). pii: e02158-18. doi: 10.1128/mBio.02158-18.

27.

Conflicted between Goal-Directed and Habitual Control, an fMRI Investigation.

Watson P, van Wingen G, de Wit S.

eNeuro. 2018 Oct 10;5(4). pii: ENEURO.0240-18.2018. doi: 10.1523/ENEURO.0240-18.2018. eCollection 2018 Jul-Aug.

28.

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis.

de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen LWMM.

Cancers (Basel). 2018 Oct 10;10(10). pii: E377. doi: 10.3390/cancers10100377.

29.

Altered Functional Connectivity in Resting State Networks in Tourette's Disorder.

Fan S, van den Heuvel OA, Cath DC, de Wit SJ, Vriend C, Veltman DJ, van der Werf YD.

Front Hum Neurosci. 2018 Sep 18;12:363. doi: 10.3389/fnhum.2018.00363. eCollection 2018.

30.

Distinctive tics suppression network in Gilles de la Tourette syndrome distinguished from suppression of natural urges using multimodal imaging.

van der Salm SMA, van der Meer JN, Cath DC, Groot PFC, van der Werf YD, Brouwers E, de Wit SJ, Coppens JC, Nederveen AJ, van Rootselaar AF, Tijssen MAJ.

Neuroimage Clin. 2018;20:783-792. doi: 10.1016/j.nicl.2018.09.014. Epub 2018 Sep 19.

31.

How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring.

Zeune LL, de Wit S, Berghuis AMS, IJzerman MJ, Terstappen LWMM, Brune C.

Cytometry A. 2018 Dec;93(12):1202-1206. doi: 10.1002/cyto.a.23576. Epub 2018 Sep 24.

32.

Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited Replication In Vivo.

Ellis S, Keep S, Britton P, de Wit S, Bickerton E, Vervelde L.

J Virol. 2018 Nov 12;92(23). pii: e01473-18. doi: 10.1128/JVI.01473-18. Print 2018 Dec 1.

33.

Evaluating Adherence to Guideline-Based Quality Indicators for Postpartum Hemorrhage Care in the Netherlands Using Video Analysis.

Woiski M, de Visser S, van Vugt H, Dijkman A, Schuitemaker N, van Meir C, Middeldorp J, Huisjes A, Mol BW, Molkenboer J, Moonen-Delarue D, Oudijk M, van Rheenen-Flach L, Rijnders R, Pernet P, Porath M, de Wit S, Grol R, Scheepers H, Hermens R.

Obstet Gynecol. 2018 Sep;132(3):656-667. doi: 10.1097/AOG.0000000000002781.

PMID:
30095761
34.

A proposed nomenclature for infectious bursal disease virus isolates.

Jackwood DJ, Schat KA, Michel LO, de Wit S.

Avian Pathol. 2018 Dec;47(6):576-584. doi: 10.1080/03079457.2018.1506092. Epub 2018 Oct 12.

PMID:
30086652
35.

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

HIV Med. 2018 Oct;19(9):605-618. doi: 10.1111/hiv.12639. Epub 2018 Jul 18.

36.

Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study.

Martin C, Castaigne C, Vierasu I, Garcia C, Wyndham-Thomas C, de Wit S.

Clin Nucl Med. 2018 Sep;43(9):635-640. doi: 10.1097/RLU.0000000000002187.

PMID:
30015658
37.

Shifting the balance between goals and habits: Five failures in experimental habit induction.

de Wit S, Kindt M, Knot SL, Verhoeven AAC, Robbins TW, Gasull-Camos J, Evans M, Mirza H, Gillan CM.

J Exp Psychol Gen. 2018 Jul;147(7):1043-1065. doi: 10.1037/xge0000402.

38.

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.

Shepherd L, Ryom L, Law M, Petoumenos K, Hatleberg CI, d'Arminio Monforte A, Sabin C, Bower M, Bonnet F, Reiss P, de Wit S, Pradier C, Weber R, El-Sadr W, Lundgren J, Mocroft A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

Clin Infect Dis. 2019 Feb 1;68(4):650-657. doi: 10.1093/cid/ciy508.

PMID:
29912335
39.

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.

Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Stephan C, Rockstroh J, Giacomelli A, Vera J, Bernardino JI, Winston A, Saumoy M, Gras J, Katlama C, Pozniak AL; European Network for AIDS Treatment 022 (NEAT022) Study Group .

Clin Infect Dis. 2019 Feb 1;68(4):597-606. doi: 10.1093/cid/ciy505.

PMID:
29912307
40.

Medial Frontal Hyperactivation in the Developing Obsessive-Compulsive Disorder Brain: An Adaptive Response Rescued by Medication-Related Reduction of Limbic Interference?

van den Heuvel OA, de Wit SJ.

J Am Acad Child Adolesc Psychiatry. 2018 Jun;57(6):368-369. doi: 10.1016/j.jaac.2018.03.011.

PMID:
29859551
41.

Associations between serum albumin and serious non-AIDS events among people living with HIV.

Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, d'Arminio Monforte A, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study Group.

AIDS. 2018 Aug 24;32(13):1837-1848. doi: 10.1097/QAD.0000000000001900.

42.

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort Analysis.

Achhra AC, Sabin C, Ryom L, Hatleberg C, Antonella dʼAminio M, de Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D Study Group.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):579-588. doi: 10.1097/QAI.0000000000001722.

PMID:
29771788
43.

Emotion Regulation in Obsessive-Compulsive Disorder, Unaffected Siblings, and Unrelated Healthy Control Participants.

Thorsen AL, de Wit SJ, de Vries FE, Cath DC, Veltman DJ, van der Werf YD, Mataix-Cols D, Hansen B, Kvale G, van den Heuvel OA.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Apr;4(4):352-360. doi: 10.1016/j.bpsc.2018.03.007. Epub 2018 Mar 24.

PMID:
29753591
44.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.

Lancet HIV. 2018 Jun;5(6):e291-e300. doi: 10.1016/S2352-3018(18)30043-2. Epub 2018 May 3.

PMID:
29731407
45.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

De Wit S, Florence E, Vandekerkhove L, Goffard JC, Vandercam B, Van Wijngaerden E, Moutschen M, Demeester R, Lacor P, Delforge M, van Frankenhuijsen M, Lacante P.

Acta Clin Belg. 2019 Jun;74(3):143-150. doi: 10.1080/17843286.2018.1462753. Epub 2018 May 2.

PMID:
29718781
46.

Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study.

Libois A, Hallin M, Crucitti T, Delforge M, De Wit S.

PLoS One. 2018 Apr 26;13(4):e0196217. doi: 10.1371/journal.pone.0196217. eCollection 2018.

47.

Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients.

De Wit S, Florence E, Vandekerckhove L, Vandercam B, Goffard JC, Van Wijngaerden E, Moutschen M, Demeester R, Thilakarathne P, Piryns H; BREACH* Consortium.

Acta Clin Belg. 2018 Oct;73(5):341-347. doi: 10.1080/17843286.2018.1458428. Epub 2018 Apr 6.

48.

Dolutegravir as a trigger for DRESS syndrome?

Martin C, Payen MC, De Wit S.

Int J STD AIDS. 2018 Sep;29(10):1036-1038. doi: 10.1177/0956462418764973. Epub 2018 Apr 5.

PMID:
29621952
49.

Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.

Dauby N, Martin C, Hainaut M, Grammens T, Van den Wijngaert S, Delforge M, De Wit S.

HIV Med. 2018 Jul;19(6):426-429. doi: 10.1111/hiv.12610. Epub 2018 Mar 24.

PMID:
29573535
50.

In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.

Payen MC, De Wit S.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):465-466. doi: 10.5588/ijtld.18.0055-2. No abstract available.

PMID:
29562999

Supplemental Content

Loading ...
Support Center